At mid-afternoon, we’ve seen some changes among today’s big movers. On the plus side are Medivation Inc. (NASDAQ: MDVN, Live Deal Inc. (NASDAQ: LIVE, RadiSys Corp. (NASDAQ: RSYS), Savient Pharmaceuticals Inc. (NASDAQ: SVNT), and Vringo Inc. (NASDAQ: VRNG).
Medivation has jumped nearly 25% to $69.12 after posting a new 52-week high of $70.87 earlier today. The development stage drug maker has reported highly positive results on a test of its late-stage prostate cancer treatment. We have more coverage here.
Live Deal is up nearly 25% at $5.47. The customer acquisition company got a capital infusion on Monday from the private equity division of Isaac Organization.
RadiSys is up nearly 22% at $7.35 in a 52-week range of $4.01-$9.38. The company has announced a ruggedized version of a Core processor from Intel Corp. (NASDAQ: INTC).
Savient is down more than 12% at $2.22. The drug company lost its CEO, who has joined Dendreon Corp. (NASDAQ: DNDN) as its new CEO.
Vringo is down nearly -6% at $1.32. The social media company is giving back some of the 30% gain it enjoyed yesterday.
The DJIA is up 1% at around 12,760, the S&P 500 is up 1.19% at about 1,328, and the Nasdaq Composite is up 1.33% at about 2,851.
Paul Ausick
Take This Retirement Quiz To Get Matched With A Financial Advisor (Sponsored)
Take the quiz below to get matched with a financial advisor today.
Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests.
Here’s how it works:
1. Answer SmartAsset advisor match quiz
2. Review your pre-screened matches at your leisure. Check out the
advisors’ profiles.
3. Speak with advisors at no cost to you. Have an introductory call on the phone or introduction in person and choose whom to work with in the future
Take the retirement quiz right here.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
